Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia

被引：24

作者：

Thornburg, CD ^{[1
]}

Pipe, SW ^{[1
]}

机构：

[1] Univ Michigan, Med Ctr, Womens Hosp, Ann Arbor, MI 48109 USA

来源：

关键词：

D O I：

10.1111/j.1365-2516.2006.01172.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：198 / 199

页数：2

共 6 条

[1]

Becker M.H., 1979, COMPLIANCE HLTH CARE, P78

[2]

Berntorp E, 1995, B WORLD HEALTH ORGAN, V73, P691

[3] Barriers to compliance with prophylaxis therapy in haemophilia [J].

Hacker, MR ;

Geraghty, S ;

Manco-Johnson, M .

[4]

*MED SCI ADV COUNC, 1994, MASAC REC CONC PROPH

[5] Economics of prophylactic treatment [J].

Schramm, W ;

Berger, K .

[6] Why is primary prophylaxis underutilized in the United States? [J].

Shapiro, AD .